Foghorn Therapeutics Inc. (FHTX)
NASDAQ·Healthcare·Biotechnology
$3.89
-8.37%
Mkt Cap $297.68M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+208.9%
Consensus $12.00 vs current $3.89
NASDAQ·Healthcare·Biotechnology
$3.89
-8.37%
Mkt Cap $297.68M
No recent rating data.
Price Target (9 analysts)
$12.00
Range $12.00 – $12.00
+208.9%
Consensus $12.00 vs current $3.89